| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.39B | 63.72B | 58.74B | 54.56B | 46.74B | 40.62B |
| Gross Profit | 14.29B | 14.04B | 13.76B | 13.30B | 11.30B | 9.20B |
| EBITDA | 10.60B | 10.74B | 11.10B | 10.19B | 8.65B | 6.50B |
| Net Income | 5.10B | 4.87B | 5.79B | 5.32B | 4.36B | 2.97B |
Balance Sheet | ||||||
| Total Assets | 75.49B | 71.59B | 67.84B | 60.27B | 54.03B | 46.76B |
| Cash, Cash Equivalents and Short-Term Investments | 24.72B | 23.41B | 22.79B | 21.67B | 18.24B | 16.31B |
| Total Debt | 4.69B | 321.46M | 381.21M | 469.07M | 1.37B | 566.67M |
| Total Liabilities | 26.68B | 21.95B | 20.61B | 18.46B | 17.46B | 13.87B |
| Stockholders Equity | 45.43B | 46.29B | 44.30B | 39.33B | 34.52B | 31.07B |
Cash Flow | ||||||
| Free Cash Flow | 623.18M | 4.40B | 2.74B | 5.43B | 2.71B | 1.06B |
| Operating Cash Flow | 1.87B | 7.84B | 5.88B | 7.89B | 6.61B | 4.63B |
| Investing Cash Flow | -1.58B | -3.87B | -2.61B | -2.64B | -4.35B | -4.14B |
| Financing Cash Flow | -472.80M | -3.20B | -2.38B | -2.15B | -763.86M | -1.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥56.15B | 20.65 | ― | 3.33% | 9.63% | 11.40% | |
74 Outperform | ¥88.01B | 14.97 | 11.16% | 3.41% | 10.87% | -5.96% | |
69 Neutral | ¥297.67B | 14.55 | 30.73% | 2.20% | 4.52% | ― | |
66 Neutral | ¥68.12B | 12.14 | ― | 2.18% | 12.03% | 30.12% | |
65 Neutral | ¥41.55B | 18.51 | ― | 2.59% | 4.02% | 18.12% | |
65 Neutral | ¥18.39B | 30.65 | ― | 1.13% | 3.37% | 9.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |